Recombinant Human Erythropoietin Pretreatment Attenuates Heart Ischemia-Reperfusion Injury in Rats by Suppressing the Systemic Inflammatory Response

被引:37
作者
Shen, Y. [1 ]
Wang, Y. [1 ]
Li, D. [1 ]
Wang, C. [1 ]
Xu, B. [1 ]
Dong, G. [1 ]
Huang, H. [1 ]
Jing, H. [1 ]
机构
[1] Nanjing Univ, Dept Cardiothorac Surg, Jinling Hosp, Sch Clin Med, Nanjing 210002, Jiangsu Prov, Peoples R China
关键词
NITRIC-OXIDE SYNTHASE; MYOCARDIAL ISCHEMIA; ARRHYTHMIAS;
D O I
10.1016/j.transproceed.2009.11.050
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Ischemia-reperfusion (I/R) injury may influence graft function after transplantation. Erythropoietin (EPO) attenuates I/R injury in various animal organs such as intestine, brain, and kidney. Objective. To evaluate the effects of pretreatment with recombinant human EPO (rhEPO) on I/R-induced heart injury. Materials and Methods. A rat model of I/R injury was established by ligating the left descending coronary artery for 30 minutes, followed by reperfusion for 4 hours. Fifty Sprague-Dawley rats were divided into 5 groups: sham operation; I/R; I/R+rhEPO, 100 U/kg; I/R+rhEPO, 1000 U/kg; and I/R+rhEPO, 5000 U/kg. Electrocardiograms were assessed continuously to note arrhythmia caused by reperfusion. Serum concentrations of interleukin (IL)-6 and IL-8, and tumor necrosis factor-alpha were measured at 2 and 4 hours after reperfusion. Results. The rhEPO-treated animals exhibited dosage-dependent significant reduction in the incidence of ventricular arrhythmia caused by reperfusion, and markedly decreased serum concentrations of IL-6, IL-8, and tumor necrosis factor-alpha (P < .05) compared with the I/R group (P < .05). Conclusion. The rhEPO attenuates myocardial I/R injury in rats, at least in part related to inhibition of the system inflammatory response.
引用
收藏
页码:1595 / 1597
页数:3
相关论文
共 8 条
[1]   Erythropoietin Protects the Heart from Ventricular Arrhythmia during Ischemia and Reperfusion via Neuronal Nitric-Oxide Synthase [J].
Burger, Dylan E. ;
Xiang, Fu-Li ;
Hammoud, Lamis ;
Jones, Douglas L. ;
Feng, Qingping .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (03) :900-907
[2]   QUANTIFICATION OF ARRHYTHMIAS USING SCORING SYSTEMS - AN EXAMINATION OF 7 SCORES IN AN INVIVO MODEL OF REGIONAL MYOCARDIAL ISCHEMIA [J].
CURTIS, MJ ;
WALKER, MJA .
CARDIOVASCULAR RESEARCH, 1988, 22 (09) :656-665
[3]   Inhibitory effect of IL-8 on insulin action in human adipocytes via MAP kinase pathway [J].
Kobashi, Chikaaki ;
Asamizu, Sachie ;
Ishiki, Manabu ;
Iwata, Minoru ;
Usui, Isao ;
Yamazaki, Katusuya ;
Tobe, Kazuyuki ;
Kobayashi, Masashi ;
Urakaze, Masaharu .
JOURNAL OF INFLAMMATION-LONDON, 2009, 6
[4]  
Liu XM, 2006, INDIAN J MED RES, V124, P343
[5]   New avenues of exploration for erythropoietin [J].
Maiese, K ;
Li, FQ ;
Chong, ZZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (01) :90-95
[6]   BRIEF, INTERMEDIATE AND PROLONGED ISCHEMIA IN THE ISOLATED CRYSTALLOID PERFUSED RAT-HEART - RELATIONSHIP BETWEEN SUSCEPTIBILITY TO ARRHYTHMIAS AND DEGREE OF ULTRASTRUCTURAL INJURY [J].
RAVINGEROVA, T ;
TRIBULOVA, N ;
SLEZAK, J ;
CURTIS, MJ .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (09) :1937-1951
[7]   Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats [J].
Ren, Binhui ;
Shen, Yi ;
Shao, Hongtao ;
Qian, Jianjun ;
Wu, Haiwei ;
Jing, Hua .
CLINICA CHIMICA ACTA, 2007, 377 (1-2) :83-87
[8]   Ulinastatin suppresses systemic inflammatory response following lung ischemia-reperfusion injury in rats [J].
Xu, L. ;
Ren, B. ;
Li, M. ;
Jiang, F. ;
Zhanng, Z. ;
Hu, J. .
TRANSPLANTATION PROCEEDINGS, 2008, 40 (05) :1310-1311